Indian pharmaceutical major Lupin Limited has acquired Hormosan Pharma, a German Sales and Marketing firm for an undisclosed amount.
Hormosan, with total sales of Euro 6.8 million for the year ended December 2007, develops, licenses and markets a range of generics in Germany and specializes in the supply of pharmaceutical products for the central nervous system.     

Besides strong key account management the company also has a successful Regulatory team, Pharmacovigilance, Medical Information and Marketing teams.

Lupin has posted a net profit of Rs 112 crore for the quarter ended June 2008, with a 101 per cent increase over Rs 55.9 crore posted during the corresponding previous year quarter.